Clinical Trials Directory

Trials / Completed

CompletedNCT02983773

Marijuana's Impact on Alcohol Motivation and Consumption

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
21 Years – 44 Years
Healthy volunteers
Accepted

Summary

This laboratory study will employ a repeated measures experimental design to examine the effect of high (7.2% THC) and moderate (3% THC) dose of marijuana, relative to placebo, on alcohol craving and on behavioral economic measure of alcohol demand after exposure to alcohol cues, and on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consume. The study will recruit 173 non-treatment seeking heavy episodic alcohol drinkers who smoke marijuana at least twice weekly.

Detailed description

This laboratory study will employ a repeated measures experimental design to examine the effect of high (7.2% THC) and moderate (3.0% THC) dose of marijuana, relative to placebo, on alcohol craving and on behavioral economic measure of alcohol demand after exposure to alcohol cues, and on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Moderators of the marijuana's effects on alcohol-related dependent variables will be tested: DSM5 alcohol use disorder severity, affective vulnerability, trait impulsivity, and working memory functioning. Several empirically-determined mechanisms that may explain why marijuana may increase risk of alcohol relapse and help maintain heavy drinking will be tested as mediators of marijuana's effects on alcohol. The study will recruit 173 non-treatment seeking heavy episodic alcohol drinkers who smoke marijuana at least twice weekly to obtain the final sample of 150 with complete data (15% of attrition). Participants will be tested at a baseline session and during three experimental sessions. Investigators will collect blood samples for analysis of cannabinoid plasma levels and to examine marijuana-induced changes in hormones and other biomarkers potentially related to appetite, inflammation and stress. Collection of these biomarkers would allow for a greater understanding about the mechanisms whereby marijuana may acutely increase alcohol motivation and use. The findings will inform researchers and clinicians about how marijuana acutely increases alcohol craving and consumption. The strategy of this proposal is to use the most comprehensive controlled test characterizing marijuana's putative effects on alcohol.

Conditions

Interventions

TypeNameDescription
DRUGTHC 7.2%1 smoked marijuana cigarette with 7.2% THC
DRUGTHC 3.0%1 smoked marijuana cigarette with 3.0% THC
DRUGPlacebo1 smoked placebo marijuana cigarette

Timeline

Start date
2017-01-23
Primary completion
2021-07-21
Completion
2021-07-21
First posted
2016-12-06
Last updated
2021-09-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02983773. Inclusion in this directory is not an endorsement.